Literature DB >> 33728518

Structural aspects of rod opsin and their implication in genetic diseases.

Francesca Fanelli1,2, Angelo Felline3, Valeria Marigo4,5.   

Abstract

Vision in dim-light conditions is triggered by photoactivation of rhodopsin, the visual pigment of rod photoreceptor cells. Rhodopsin is made of a protein, the G protein coupled receptor (GPCR) opsin, and the chromophore 11-cis-retinal. Vertebrate rod opsin is the GPCR best characterized at the atomic level of detail. Since the release of the first crystal structure 20 years ago, a huge number of structures have been released that, in combination with valuable spectroscopic determinations, unveiled most aspects of the photobleaching process. A number of spontaneous mutations of rod opsin have been found linked to vision-impairing diseases like autosomal dominant or autosomal recessive retinitis pigmentosa (adRP or arRP, respectively) and autosomal congenital stationary night blindness (adCSNB). While adCSNB is mainly caused by constitutive activation of rod opsin, RP shows more variegate determinants affecting different aspects of rod opsin function. The vast majority of missense rod opsin mutations affects folding and trafficking and is linked to adRP, an incurable disease that awaits light on its molecular structure determinants. This review article summarizes all major structural information available on vertebrate rod opsin conformational states and the insights gained so far into the structural determinants of adCSNB and adRP linked to rod opsin mutations. Strategies to design small chaperones with therapeutic potential for selected adRP rod opsin mutants will be discussed as well.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Conformational diseases; GPCRs; Molecular simulations; Protein structure networks; Rhodopsin

Mesh:

Substances:

Year:  2021        PMID: 33728518     DOI: 10.1007/s00424-021-02546-x

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  162 in total

1.  Signaling states of rhodopsin: absorption of light in active metarhodopsin II generates an all-trans-retinal bound inactive state.

Authors:  F J Bartl; E Ritter; K P Hofmann
Journal:  J Biol Chem       Date:  2001-05-30       Impact factor: 5.157

2.  Transducin activation by nanoscale lipid bilayers containing one and two rhodopsins.

Authors:  Timothy H Bayburt; Andrew J Leitz; Guifu Xie; Daniel D Oprian; Stephen G Sligar
Journal:  J Biol Chem       Date:  2007-03-29       Impact factor: 5.157

3.  An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors.

Authors:  J M Baldwin; G F Schertler; V M Unger
Journal:  J Mol Biol       Date:  1997-09-12       Impact factor: 5.469

Review 4.  How photons start vision.

Authors:  D Baylor
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

5.  Two different forms of metarhodopsin II: Schiff base deprotonation precedes proton uptake and signaling state.

Authors:  S Arnis; K P Hofmann
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

Review 6.  The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy.

Authors:  Dimitra Athanasiou; Monica Aguila; James Bellingham; Wenwen Li; Caroline McCulley; Philip J Reeves; Michael E Cheetham
Journal:  Prog Retin Eye Res       Date:  2017-10-16       Impact factor: 21.198

7.  Altered functionality in rhodopsin point mutants associated with retinitis pigmentosa.

Authors:  Anna Andrés; Pere Garriga; Joan Manyosa
Journal:  Biochem Biophys Res Commun       Date:  2003-03-28       Impact factor: 3.575

8.  Constitutively signaling G-protein-coupled receptors and human disease.

Authors:  L Arvanitakis; E Geras-Raaka; M C Gershengorn
Journal:  Trends Endocrinol Metab       Date:  1998 Jan-Feb       Impact factor: 12.015

9.  The probable arrangement of the helices in G protein-coupled receptors.

Authors:  J M Baldwin
Journal:  EMBO J       Date:  1993-04       Impact factor: 11.598

10.  Hsp90 inhibition protects against inherited retinal degeneration.

Authors:  Mònica Aguilà; Dalila Bevilacqua; Caroline McCulley; Nele Schwarz; Dimitra Athanasiou; Naheed Kanuga; Sergey S Novoselov; Clemens A K Lange; Robin R Ali; James W Bainbridge; Carlos Gias; Peter J Coffey; Pere Garriga; Michael E Cheetham
Journal:  Hum Mol Genet       Date:  2013-12-02       Impact factor: 6.150

View more
  5 in total

1.  Chromenone derivatives as novel pharmacological chaperones for retinitis pigmentosa-linked rod opsin mutants.

Authors:  Joseph T Ortega; Andrew G McKee; Francis J Roushar; Wesley D Penn; Jonathan P Schlebach; Beata Jastrzebska
Journal:  Hum Mol Genet       Date:  2022-10-10       Impact factor: 5.121

2.  The role of motor proteins in photoreceptor protein transport and visual function.

Authors:  Rakesh Radhakrishnan; Venkateshwara R Dronamraju; Matthias Leung; Andrew Gruesen; Ashish K Solanki; Stephen Walterhouse; Heidi Roehrich; Grace Song; Rafael da Costa Monsanto; Sebahattin Cureoglu; René Martin; Altaf A Kondkar; Frederik J van Kuijk; Sandra R Montezuma; Hans-Joachim Knöelker; Robert B Hufnagel; Glenn P Lobo
Journal:  Ophthalmic Genet       Date:  2022-04-26       Impact factor: 1.274

3.  New insights into the molecular mechanism of rhodopsin retinitis pigmentosa from the biochemical and functional characterization of G90V, Y102H and I307N mutations.

Authors:  María Guadalupe Herrera-Hernández; Neda Razzaghi; Pol Fernandez-Gonzalez; Laia Bosch-Presegué; Guillem Vila-Julià; Juan Jesús Pérez; Pere Garriga
Journal:  Cell Mol Life Sci       Date:  2022-01-07       Impact factor: 9.261

4.  Where vision begins.

Authors:  Daniele Dell'Orco; Karl-Wilhelm Koch; Giorgio Rispoli
Journal:  Pflugers Arch       Date:  2021-09       Impact factor: 4.458

5.  Protein structural features predict responsiveness to pharmacological chaperone treatment for three lysosomal storage disorders.

Authors:  Jaie Woodard; Wei Zheng; Yang Zhang
Journal:  PLoS Comput Biol       Date:  2021-09-16       Impact factor: 4.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.